Novel pharmacologic approaches to reduce bleeding.
Levy
Jerrold H
JH
Department of Anesthesiology, Emory University School of Medicine, Division of Cardiothoracic Anesthesiology and Critical Care, Emory Healthcare, Atlanta, Georgia 30322, USA. jerrold_levy@emory.org
D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D000991:Antithrombins / Q000494:pharmacology / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D006470:Hemorrhage / Q000188:drug therapy* / Q000517:prevention & control*; D006493:Heparin / Q000627:therapeutic use; D006494:Heparin Antagonists / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D000991:Antithrombins; D006494:Heparin Antagonists; D011994:Recombinant Proteins; D006493:Heparin; D007611:Aprotinin; D003894:Deamino Arginine Vasopressin